Abiopharma

🔍 Marquette Travis (Executive)

Company: Burlington Stores, Inc. (BURL)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Sold 9 shares of Common Stock at $311.33 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 27,490.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 163 shares of Common Stock at $313.62 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 27,327.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 18 shares of Common Stock at $315.42 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 27,309.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $311.32 and $311.43. The reporting person undertakes to provide to Burlington Stores, Inc., any security holder of Burlington Stores, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
• F2: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2025.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.17 to $314.02. The reporting person undertakes to provide to Burlington Stores, Inc., any security holder of Burlington Stores, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.